← Back to Search

Behavioural Intervention

Augmented Reality Rehabilitation for Acquired Brain Injury

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights

Study Summary

This trial seeks to use AR to make rehab therapies more engaging & fun for ABI patients, improving adherence & clinical outcomes.

Who is the study for?
This trial is for adults at the Glenrose Rehabilitation Hospital in Edmonton, Canada with mild to moderate acquired brain injury. Participants must speak English and have enough upper-limb strength and coordination to use an AR headset. It's not for children, those with severe brain injuries or cognitive disorders, severe aphasia, communication disorders that affect understanding verbal commands, previous neurological/psychiatric conditions, substance misuse issues, or impairments limiting interaction with AR.Check my eligibility
What is being tested?
The study tests augmented reality (AR) therapies called GlenXRose for acquired brain injury rehabilitation. The goal is to see if gamifying therapy through AR can make it more engaging and improve patient adherence compared to traditional methods. This will be assessed alongside routine care while considering clinician feedback and financial costs.See study design
What are the potential side effects?
While specific side effects are not detailed in this summary, potential side effects may include discomfort from using the AR headset or fatigue due to increased engagement during rehabilitation sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence - Attendance
Adherence - Clinician Reported
Adherence - Self Reported
+3 more
Secondary outcome measures
Cognitive Functioning - Behaviour
Cognitive Functioning - LOTCA
Cognitive Functioning - SCATBI
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Augmented Reality Delivered Therapy + Standard Clinical CareExperimental Treatment1 Intervention
The GlenXRose augmented reality therapies will be delivered to participants using a head-mounted device to allow acquired brain injury rehabilitation therapy and practice. Participants will also receive routine clinical care provided by clinicians.
Group II: Standard Clinical CareActive Control1 Intervention
Participants will receive routine clinical care provided by clinicians.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,147 Total Patients Enrolled
Alberta Health servicesOTHER
158 Previous Clinical Trials
649,636 Total Patients Enrolled
MitacsIndustry Sponsor
38 Previous Clinical Trials
4,331 Total Patients Enrolled

Media Library

GlenXRose Augmented Reality Acquired Brian Injury Therapies (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05897593 — N/A
Acquired Brain Injury Research Study Groups: Augmented Reality Delivered Therapy + Standard Clinical Care, Standard Clinical Care
Acquired Brain Injury Clinical Trial 2023: GlenXRose Augmented Reality Acquired Brian Injury Therapies Highlights & Side Effects. Trial Name: NCT05897593 — N/A
GlenXRose Augmented Reality Acquired Brian Injury Therapies (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05897593 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What aim is this experiment striving to accomplish?

"Over a 12 week period, this study strives to make broad generalizations. The secondary objectives include assessing cognitive functioning with the Lowenstein Occupational Therapy Cognitive Assessment (LOTCA), which involves 26 subtests rated on a scale of 1-4 indicating varying levels of performance. Additionally, data will be collected for behavioural inattention and upper limb motor coordination using the Behavioural Inattention Test and Box and Block test respectively; both tests involve comparison against established norms, where higher scores reflect better results."

Answered by AI

Are there any opportunities to join this trial at the present time?

"According to clinicaltrials.gov, the recruitment for this particular medical study has been discontinued. Initially posted on October 1st 2023 and last edited on June 8th 2023, this trial is not currently seeking any participants although there are 1993 other studies that are actively searching for candidates at present."

Answered by AI

Who else is applying?

What site did they apply to?
Glenrose Rehabilitation Hospital
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

To further medical technology for a possible cure.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Clinical Feasibility & Validation of the Augmented Reality GlenxRose Acquired Brain Injury Rehabilitation Programs
2024. "Clinical Feasibility & Validation of the Augmented Reality GlenxRose Acquired Brain Injury Rehabilitation Programs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05897593.
~20 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top